Compare Immunovant Inc. Common Stock (IMVT) vs Navan Inc. Class A Common Stock (NAVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Navan Inc. Class A Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Navan Inc. Class A Common Stock trades at $23.16 (market cap $5.80B). The key difference: Immunovant Inc. Common Stock and Navan Inc. Class A Common Stock are close in size by market cap, and Navan Inc. Class A Common Stock is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Navan Inc. Class A Common Stock for 0 Days on average.
| IMVT | NAVN | |
|---|---|---|
Market Cap | $6.62B | $5.80B |
Volume | 1,131,364 | 3,022,922 |
Sector | Health | Technology |
52-Week High | $44.96 | $30.58 |
52-Week Low | $17.03 | $8.51 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $5.15B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Navan Inc. Class A Common Stock
Navan provides an AI-powered platform for business travel, payments, and expense management. Its tools support trip booking, policy controls, payment processing, expense reconciliation, and reporting.
Read more on NAVN →
